(Reuters) - Roper Technologies raised its full-year profit and revenue forecasts above Wall Street estimates on Wednesday on improved demand for its enterprise software services that cater to ...
Boston Scientific exceeded Q3 expectations with $4.21 billion revenue and $0.63 EPS. Cardiovascular sales rose 25%, and 2024 growth guidance was updated.